| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |